SCHEMBL10145280

SCHEMBL10145280

O=C(NN1CCCCC1)c1nn(-c2ccc(Cl)cc2Cl)c(-c2ccc(CCO)cc2)c1CO

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 12/20 0.73
CNR2 P34972 8/20 0.73
CYP2C9 P11712 2/20 0.66
GPR55 Q9Y2T6 2/20 0.66
ABCC4 O15439 1/20 0.66
MLNR O43193 1/20 0.66
ABCB11 O95342 1/20 0.66
CHRM2 P08172 1/20 0.66
ADORA3 P0DMS8 1/20 0.66
ADRA2B P18089 1/20 0.66
ADRA2C P18825 1/20 0.66
DRD1 P21728 1/20 0.66
TBXA2R P21731 1/20 0.66
SLC6A2 P23975 1/20 0.66
HRH2 P25021 1/20 0.66
HTR2A P28223 1/20 0.66
AGTR1 P30556 1/20 0.66
CCKAR P32238 1/20 0.66
CCKBR P32239 1/20 0.66
MC4R P32245 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2627927 0.95 CNR1 (0.71) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL2627924 0.94 CNR1 (0.70) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL2633165 0.94 CNR1 (0.77) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL7770518 0.93 CNR1 (0.81) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL2633211 0.91 CNR1 (0.69) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL4909775 0.90 CNR1 (0.77) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL2627956 0.90 CNR1 (0.83) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL12053804 0.89 CNR1 (0.85) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL4913336 0.88 CNR1 (0.79) CNR1CNR2CYP2C9GPR55ABCC4
SCHEMBL12053842 0.87 CNR1 (0.72) CNR1CNR2CYP2C9GPR55ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095047-A1 Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors UNIVERSITY OF CONNECTICUT (US) 2012-04-19 US disclosed
US-8084451-B2 Heteropyrrole analogs acting on cannabinoid receptors UNIVERSITY OF CONNECTICUT (US) 2011-12-27 US disclosed
US-20100063050-A1 NOVEL HETEROPYRROLE ANALOGS ACTING ON CANNABINOID RECEPTORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095047-A1 Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors CNR2, CNR1, GPR18 CNR1 2/4885CNR2 1/4885CYP2C9 1185/4885
US-20100063050-A1 NOVEL HETEROPYRROLE ANALOGS ACTING ON CANNABINOID RECEPTORS CNR2, CNR1, GPR18 CNR1 2/4885CNR2 1/4885CYP2C9 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.